Cargando…

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer

Cancer cells resist the immune response in a process known as immune editing or immune evasion. Therapies that target the immune system have revolutionized cancer treatment; however, immunotherapies have been ineffective for the majority of ovarian cancer cases. In this issue of the JCI, Chen, Xie,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiappinelli, Katherine B., Baylin, Stephen B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282922/ https://www.ncbi.nlm.nih.gov/pubmed/35838045 http://dx.doi.org/10.1172/JCI160186

Ejemplares similares

Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
por: Siebenkäs, Cornelia, et al.
Publicado: (2017)

Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
por: Siebenkäs, Cornelia, et al.
Publicado: (2020)

DNA methylation in senescence, aging and cancer
por: Xie, Wenbing, et al.
Publicado: (2019)

Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
por: Gomez, Stephanie, et al.
Publicado: (2022)

Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
por: Boreel, Daan F, et al.
Publicado: (2021)

Multi-kinase inhibition in ovarian cancer
por: Dent, Paul
Publicado: (2014)

CD4 T Cells and Their Role in Antitumor Immune Responses
por: Toes, René E.M., et al.
Publicado: (1999)

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
por: Li, Huili, et al.
Publicado: (2014)

Kinetics reshape antitumor immunity: Timing, duration, and combination are of importance for successful cancer immunotherapy
por: Jin, Seung Mo, et al.
Publicado: (2023)

A Translational Perspective of a Deubiquitinase Inhibitor in Antitumor Immunity
por: Li, Yangyang, et al.
Publicado: (2016)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Epigenetic therapy for ovarian cancer: promise and progress
por: Moufarrij, Sara, et al.
Publicado: (2019)

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
por: Ding, Liya, et al.
Publicado: (2018)

DNA methylation in cancer: From mouse to human and back again
por: Esteller, Manel
Publicado: (2021)

Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
por: Waki, Kayoko, et al.
Publicado: (2020)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Antitumor activity of LSD1 inhibitors in lung cancer
por: Mohammad, Helai P., et al.
Publicado: (2016)

DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer
por: Tost, Jörg
Publicado: (2015)

Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells
por: Cai, Yi, et al.
Publicado: (2017)

Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma
por: Liu, Xiaomeng, et al.
Publicado: (2022)

Editorial: Genetic and Epigenetic Control of Immune Responses
por: Noonepalle, Satish kumar R., et al.
Publicado: (2021)

Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island
por: O'Hagan, Heather M., et al.
Publicado: (2008)

DNA Methylation and Chromatin: Role(s) of Methyl-CpG-Binding Protein ZBTB38
por: de Dieuleveult, Maud, et al.
Publicado: (2018)

DNA-damaging cancer cells to improve virotherapy
por: Garcia-Moure, Marc, et al.
Publicado: (2022)

Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
por: Shirakawa, Toshiro, et al.
Publicado: (2017)

PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer
por: Yang, Yishi, et al.
Publicado: (2021)

DNA Methylation in Ovarian Cancer Susceptibility
por: Reid, Brett M., et al.
Publicado: (2020)

Clinical applications of DNA methylation profiling in lung cancer
por: Castro-Gonzalez, Sergio, et al.
Publicado: (2023)

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
por: Devapatla, Bharat, et al.
Publicado: (2015)

CRISPR-Cas immunity and mobile DNA: a new superfamily of DNA transposons encoding a Cas1 endonuclease
por: Hickman, Alison B, et al.
Publicado: (2014)

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
por: Chen, Siqi, et al.
Publicado: (2022)

Epigenetics in glaucoma: a link between DNA methylation and neurodegeneration
por: Liu, Wendy W., et al.
Publicado: (2022)

Epigenome-Wide Association Studies of DNA Methylation in Kidney Diseases
por: Luan, Junjun, et al.
Publicado: (2022)

PcG Proteins, DNA Methylation, and Gene Repression by Chromatin Looping
por: Tiwari, Vijay K, et al.
Publicado: (2008)

Hepatic metastases in ovarian cancer
por: Shan, Ying, et al.
Publicado: (2022)

Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
por: Moufarrij, Sara, et al.
Publicado: (2020)

DNA methylation subtypes for ovarian cancer prognosis
por: Yin, Lili, et al.
Publicado: (2021)

Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
por: Yu, Ping, et al.
Publicado: (2023)

Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model
por: Sociali, Giovanna, et al.
Publicado: (2015)

Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
por: Hou, Dong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mda5529bsmu11p96506r3b8dkv